Picture of CorMedix logo

CRMD CorMedix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Annual cashflow statement for CorMedix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.4-22-28.2-29.7-46.3
Depreciation
Non-Cash Items3.242.565.164.195.63
Other Non-Cash Items
Changes in Working Capital-1.93-2.631.841.072.23
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-15.1-22-21.2-24.4-38.4
Capital Expenditures-0.037-0.113-1.43-0.219-0.327
Purchase of Fixed Assets
Other Investing Cash Flow Items-127.54-7.71-3.49-16.7
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-127.43-9.13-3.71-17.1
Financing Cash Flow Items-0.2270-0.198
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25.840.141.817.955.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.2725.611.5-10.20.448